A carregar...
Tocilizumab for the treatment of chimeric antigen receptor T cell-induced cytokine release syndrome
INTRODUCTION: Cancer-directed immunotherapies are transforming the landscape in oncology as new and exciting therapies move from the laboratory to the bedside. Chimeric antigen receptor T (CAR-T) cells are one of these novel therapies, demonstrating impressive efficacy against B-cell malignancies. W...
Na minha lista:
| Publicado no: | Expert Rev Clin Immunol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7936577/ https://ncbi.nlm.nih.gov/pubmed/31219357 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/1744666X.2019.1629904 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|